BioPharma Dive ٢٧ فبراير ٢٠٢٦ Atrium spins out of Avidity, aiming to target rare heart diseases with RNA
BioPharma Dive ٦ فبراير ٢٠٢٦ White House’s online service for drug sales debuts with limited impact on prices
BioPharma Dive ١٤ يناير ٢٠٢٦ JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharma’s cell therapy view